Univ. Prof. Oliver Spadiut presented how NovoArc’s next-generation lipid platform is redefining drug delivery by enabling the oral administration of biologics, small molecules, and nucleic acids.
Key insight from the session: Stability and efficient delivery remain central challenges in therapeutic development. NovoArc’s lipid technology offers a breakthrough solution to address these barriers and unlock new possibilities in advanced therapies.
